SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-035583
Filing Date
2012-05-10
Accepted
2012-05-10 08:31:09
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a12-7444_110q.htm 10-Q 847369
2 EX-31.1 a12-7444_1ex31d1.htm EX-31.1 11710
3 EX-31.2 a12-7444_1ex31d2.htm EX-31.2 11864
4 EX-32.1 a12-7444_1ex32d1.htm EX-32.1 6459
5 EX-32.2 a12-7444_1ex32d2.htm EX-32.2 6435
  Complete submission text file 0001104659-12-035583.txt   7473708

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT irwd-20120331.xml EX-101.INS 775640
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT irwd-20120331.xsd EX-101.SCH 97089
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT irwd-20120331_cal.xml EX-101.CAL 43400
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT irwd-20120331_lab.xml EX-101.LAB 1432874
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT irwd-20120331_pre.xml EX-101.PRE 713987
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT irwd-20120331_def.xml EX-101.DEF 519036
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176
Type: 10-Q | Act: 34 | File No.: 001-34620 | Film No.: 12827825
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences